Monopar Therapeutics (NASDAQ:MNPR – Get Free Report) announced its earnings results on Thursday. The company reported ($0.48) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.48).
Source link
Image source: Getty Images Investing in quality stocks trading at a discount is a proven strategy to generate outsized gains and beat the broader indices. The market turbulence in 2025 provides long-term investors with an opportunity to buy the dip and gain exposure to undervalued TSX stocks. Moreover, if these stocks are held in a…
With volatility on the rise, investors have plenty of uncertainty to price into their potential future gains. As such, many investors are rightly rotating into more defensive names, to take the sting off of what could be a prolonged sell-off. That is, if these geopolitical conflicts continue to raise the price of oil and, in…
A large portion of Canadian-listed exchange-traded funds (ETFs) that investors gravitate toward tend to focus on U.S. stocks. Most of the time that means funds tracking well-known benchmarks such as the S&P 500 or the NASDAQ 100. These ETFs have become extremely popular because U.S. equities have been strong performers for many years. However, buying…
Belo Sun Mining (TSE:BSX) Stock Price Down 22.2% – What’s Next? Source link
Choopy sloppy summer type action with some volatility.QQQ stuck in a mini range with 450 support, 456 resistance. Quick active trades here and there. Follow me on X/Twitter for real time trading setups @szaman and on StockTwits @szaman. Watch us trade these stocks LIVE, in real-time. Click here to get started! Check out our watch list…
Source link